Korean J Pathol.
2001 Apr;35(2):158-164.
Ethnic Differences of the p53 Genetic Alteration in Cutaneous Malignant Melanoma
- Affiliations
-
- 1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea. stingray@cmc.cuk.ac.kr
- 2Department of Pathology, Chung Ang University College of Medicine, Seoul 156-756, Korea.
- 3Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.
Abstract
-
BACKGROUND: There are significant differences in the clincopathologic pattern including the incidence, favor site, and histopathologic type between cutaneous malignant melanomas arising from whites, asians and blacks. These differences might suggest that there is a racial difference in the molecular tumorigenesis mechanism of malignant melanoma.
METHODS
To determine the ethnic differences in tumorigenesis of malignant melanoma, we performed loss of heterozygosity (LOH) and sequencing analyses of the p53 gene in cutaneous malignant melanomas arising from 22 white American, 30 Korean and 15 black African patients.
RESULTS
The frequency of LOH of the p53 gene is only 12.5% in white American patients, but the frequency is significantly higher in Korean (42.1%) and black African (61.5%) patients. We also detected 17 mutations (nonsense: 1, missense: 16) of the p53 gene in the cutaneous malignant melanomas of Koreans and black Africans, but none in those of white Americans: among the 16 missense mutations, 10 mutations were C:G to T:A transitional mutations. Of these, we also detected one GG (CC) to AA (TT) tandem mutation at the pyrimidine sequence.
CONCLUSION
These results strongly suggest that there might be a racial difference in molecular carcinogenesis mechanisms among the cutaneous malignant melanomas occurring in white American, Korean and black African patients. But the role of the p53 genetic alteration in the genesis of melanomas in Korean and black African patients is subject to further evaluation.